With no NHS coverage, Jessica needed affordable options. Guided by her doctor, she sourced a generic alternative for Lenalidomide 25mg from a USFDA-approved facility with our help — saving 90% of the cost.

During a relapse, Jessica contacted us again for Pomalidomide 4mg, a generic version from an EU GMP-certified facility, at a fraction of the cost. This allowed her father to continue treatment without financial strain.

Without NHS coverage, Jessica could not afford the original drugs priced over £50k. Our Named Patient Program provided access to effective and affordable alternatives, giving her father precious additional years.

Theresa was diagnosed with stage 4 lung cancer in June 2022 and was given nine months to live. Through Named Patient Imports as per the Medicines Act of 1981 and a prescription from her oncologist, she has been procuring generic from a foreign country at a fraction of the cost of an unfunded FDA- approved treatment available in New Zealand.

The authorized version of the drug Theresa imports costs $10,000 a month in New Zealand, compared to the $1000 she currently pays for the generic medicine. Not only is the generic medicine much more affordable, but it has also proven to be effective and has caused Theresa's cancer to thin, thereby extending her life.

Theresa actively petitioned against a proposal in the Therapeutic Products Bill which could have disallowed named patient imports of affordable generics for patients like her. Fortunately, the bill was later amended and the subsequently passed Therapeutic Products Act allows multiple scenarios for named patient imports.

Mr. Jeffery’s from Australia was suffering from Hepatitis C and was on the edge of liver cirrhosis. The desperation to find a cheaper medicine led him to India.

He found the required medicine at a fraction of the cost in India and his recovery was almost immediate.

A path for Australia’s drug regulator(TGA) allows individuals to import upto 3 month’s supply of medicines for their own use(or use by a close family member) under the personal importation scheme. Personal importation may also allow you to access medicines that are available overseas but are not marketed in Australia.